Taiwan has antimalarial drug seen as possible COVID-19 treatment: CECC
03/26/2020 10:44 PM
Taipei, March 26 (CNA) Quinoline antimalarial drugs, which have recently been discussed as a possible treatment for the COVID-19 coronavirus, are produced in Taiwan and could be made available if testing proves them to be effective, the Central Epidemic Command Center (CECC) said Thursday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
U.S. to deliver 2.5 million doses of Moderna vaccine to Taiwan Sunday
06/19/2021 10:47 PM - Society
Clinic fined NT$4 million for vaccinating non-priority individuals
06/19/2021 10:27 PM - Society
COVID home test kits to go on sale in Taiwan next week: FDA
06/19/2021 09:06 PM - Society
Only 5 confirmed Delta variant cases found in Taiwan, all imported: CECC
06/19/2021 08:55 PM - Culture
NTU to erect plaque to commemorate Chen Wen-chen's death
06/19/2021 08:15 PM
